Paper42226207
A ferritin-based mosaic-like nanovaccine elicits effective cross-protection against H1N1 and H3N2 swine influenza viruses.
Han L and 8 others. J Nanobiotechnology, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. A ferritin-based mosaic-like nanovaccine elicits effective cross-protection against H1N1 and H3N2 swine influenza viruses. Papers, record 42226207. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42226207
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A ferritin-based mosaic-like nanovaccine elicits effective cross-protection against H1N1 and H3N2 swine influenza viruses.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Nanovaccines | Major topic |
| Influenza A Virus, H3N2 Subtype | Major topic |
| Ferritins | Major topic |
| Influenza A Virus, H1N1 Subtype | Major topic |
| Influenza Vaccines | Major topic |
| Orthomyxoviridae Infections | Major topic |
| Cross Protection | Major topic |
| Animals | |
| Swine | |
| Mice | |
| Female | |
| Mice, Inbred BALB C | |
| Antibodies, Viral | |
| Protein Subunit Vaccines | |
| Epitopes | |
| Hemagglutinin Glycoproteins, Influenza Virus | |
| Interleukin-4 |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| U23A20243 | National Natural Science Foundation of China | PubMed |
Source PubMed
References45
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17911588 | CD8+ CTL priming by exact peptide epitopes in incomplete Freund's adjuvant induces a vanishing CTL response, whereas long peptides induce sustained CTL reactivity. | J Immunol | 2007 | https://conductscience.org/library/papers/17911588 | PubMed |
| 2 | 37964304 | A candidate nanoparticle vaccine comprised of multiple epitopes of the African swine fever virus elicits a robust immune response. | J Nanobiotechnology | 2023 | https://conductscience.org/library/papers/37964304 | PubMed |
| 3 | 32828069 | Immunoinformatics-guided design of an epitope-based vaccine against severe acute respiratory syndrome coronavirus 2 spike glycoprotein. | Comput Biol Med | 2020 | https://conductscience.org/library/papers/32828069 | PubMed |
| 4 | 38835763 | A ferritin nanoparticle vaccine based on the hemagglutinin extracellular domain of swine influenza A (H1N1) virus elicits protective immune responses in mice and pigs. | Front Immunol | 2024 | https://conductscience.org/library/papers/38835763 | PubMed |
| 5 | 27928015 | Reassortment between Swine H3N2 and 2009 Pandemic H1N1 in the United States Resulted in Influenza A Viruses with Diverse Genetic Constellations with Variable Virulence in Pigs. | J Virol | 2017 | https://conductscience.org/library/papers/27928015 | PubMed |
| 6 | 21169548 | Universal vaccine based on ectodomain of matrix protein 2 of influenza A: Fc receptors and alveolar macrophages mediate protection. | J Immunol | 2011 | https://conductscience.org/library/papers/21169548 | PubMed |
| 7 | 23698367 | Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies. | Nature | 2013 | https://conductscience.org/library/papers/23698367 | PubMed |
| 8 | 29797225 | Emergence of Eurasian Avian-Like Swine Influenza A (H1N1) Virus from an Adult Case in Fujian Province, China. | Virol Sin | 2018 | https://conductscience.org/library/papers/29797225 | PubMed |
| 9 | 36280176 | Ferritin self-assembly, structure, function, and biotechnological applications. | Int J Biol Macromol | 2023 | https://conductscience.org/library/papers/36280176 | PubMed |
| 10 | 36992472 | Effects of SARS-CoV-2 Omicron BA.1 Spike Mutations on T-Cell Epitopes in Mice. | Viruses | 2023 | https://conductscience.org/library/papers/36992472 | PubMed |
| 11 | 38191112 | Self-adjuvant multiepitope nanovaccine based on ferritin induced long-lasting and effective mucosal immunity against H3N2 and H1N1 viruses in mice. | Int J Biol Macromol | 2024 | https://conductscience.org/library/papers/38191112 | PubMed |
| 12 | 26557805 | Mechanisms of Cross-protection by Influenza Virus M2-based Vaccines. | Immune Netw | 2015 | https://conductscience.org/library/papers/26557805 | PubMed |
| 13 | 39757928 | Nanoparticle Vaccine Triggers Interferon-Gamma Production and Confers Protective Immunity against Porcine Reproductive and Respiratory Syndrome Virus. | ACS Nano | 2025 | https://conductscience.org/library/papers/39757928 | PubMed |
| 14 | 40452158 | Epitope-Optimized Influenza Hemagglutinin Nanoparticle Vaccine Provides Broad Cross-Reactive Immunity against H9N2 Influenza Virus. | ACS Nano | 2025 | https://conductscience.org/library/papers/40452158 | PubMed |
| 15 | 30808695 | Design of Nanoparticulate Group 2 Influenza Virus Hemagglutinin Stem Antigens That Activate Unmutated Ancestor B Cell Receptors of Broadly Neutralizing Antibody Lineages. | mBio | 2019 | https://conductscience.org/library/papers/30808695 | PubMed |
| 16 | 32601207 | Prevalent Eurasian avian-like H1N1 swine influenza virus with 2009 pandemic viral genes facilitating human infection. | Proc Natl Acad Sci U S A | 2020 | https://conductscience.org/library/papers/32601207 | PubMed |
| 17 | 36219302 | Continued evolution of the Eurasian avian-like H1N1 swine influenza viruses in China. | Sci China Life Sci | 2023 | https://conductscience.org/library/papers/36219302 | PubMed |
| 18 | 30944178 | Development of Influenza B Universal Vaccine Candidates Using the "Mosaic" Hemagglutinin Approach. | J Virol | 2019 | https://conductscience.org/library/papers/30944178 | PubMed |
| 19 | 39545388 | Efficient Neutralizing Antibodies Induction by Human Parvovirus B19 Epitope-Presenting Protein Nanoparticles. | Microbiol Immunol | 2025 | https://conductscience.org/library/papers/39545388 | PubMed |
| 20 | 29367723 | Double-layered protein nanoparticles induce broad protection against divergent influenza A viruses. | Nat Commun | 2018 | https://conductscience.org/library/papers/29367723 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42226207
GET https://conductscience.org/api/papers/v1/42226207/references?page=2